Staar Surgical Co (STAA)
| Market Cap | $1.22B-11.4% |
| Revenue (ttm) | $328.27M |
| Net Income | $530.00K |
| EPS | $0.01 |
| Shares Out | 50.20M |
| PE Ratio | 2422.00 |
| Forward PE | 21.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 585,633 |
| Open | $24.73 |
| Previous Close | $25.03 |
| Day's Range | $23.86 - $25.08 |
| 52-Week Range | $15.59 - $35.87 |
| Beta | 1.20 |
| Analysts | Buy |
| Price Target | $28.56(+17.90%) |
| Earnings Date | Nov 4, 2026 |
About STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Analyst consensus
2 firms rating STAA in the last 3 months, one vote each. Issuer-paid research is not counted.
$STAA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in STAA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by STAA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
STAA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New STAA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to STAA from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from STAA’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.68% |
| SIXL | ETC 6 Meridian Low Beta Equity ETF | 0.47% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 0.42% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.42% |
| SMIZ | Zacks Small/Mid Cap ETF | 0.41% |
| DMRM | DeltaShares S&P 400 Managed Risk ETF | 0.28% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.24% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.23% |
| STSB | iShares Factors US Small Blend Style ETF | 0.19% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.11% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.08% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.07% |
Weight is the stock’s share of each fund’s holdings.
